Document Detail


Controversies about the treatment of myasthenia gravis.
MedLine Citation:
PMID:  7400825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clinicians treating patients with myasthenia gravis must choose cholinergic drugs, corticosteroids, immunosuppressive drugs, thymectomy, or plasmapheresis. Clinicians must decide the sequence or combination of these therapies and when to deem lack of improvement a sign for a different therapeutic approach. Because controlled trials have not been done to evaluate therapies that may require months or years before benefit is evident, controversy abounds.
Authors:
L P Rowland
Related Documents :
11224695 - Prevention of nephrolithiasis.
11093015 - Eeg in assessing hydroxycobalamin therapy in neonatal methylmalonic aciduria with homoc...
15239755 - Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
10582155 - Topical corticosteroid therapy in psoriasis vulgaris: update and new strategies.
7899555 - Radioprotection of mouse hemopoiesis by dipyridamole and adenosine monophosphate in fra...
16753485 - Incidence of heroin use in zurich, switzerland: a treatment case register analysis.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  43     ISSN:  0022-3050     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  1980 Jul 
Date Detail:
Created Date:  1980-10-24     Completed Date:  1980-10-24     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  644-59     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholinesterase Inhibitors / therapeutic use
Dose-Response Relationship, Drug
Humans
Immunosuppressive Agents / therapeutic use
Myasthenia Gravis / therapy*
Parasympathomimetics / therapeutic use
Plasmapheresis
Steroids / therapeutic use
Thymectomy
Chemical
Reg. No./Substance:
0/Cholinesterase Inhibitors; 0/Immunosuppressive Agents; 0/Parasympathomimetics; 0/Steroids
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immune regulation of experimental myasthenia.
Next Document:  Exercise thallium imaging: location of perfusion abnormalities in single-vessel coronary disease.